Evidence map›Paper›PMID 34698100›Full record

ArticleCurrent issues in molecular biology2021

Contribution of Neuropilin-1 in Radiation-Survived Subclones of NSCLC Cell Line H1299.

Kaori Tsutsumi, Ayaka Chiba, Yuta Tadaki, Shima Minaki, Takahito Ooshima, Haruka Takahashi

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Kaori TsutsumiFaculty of Health Sciences, Hokkaido University, Sapporo 060-0812, Japan.ORCID 0000-0002-3003-4290
Ayaka ChibaDivision of Radiology and Nuclear Medicine, Sapporo Medical University Hospital, Sapporo 060-8556, Japan.
Yuta TadakiDepartment of Radiological Technology, Saiseikai Otaru Hospital, Otaru 047-0008, Japan.
Shima MinakiDepartment of Radiological Technology, Sapporo Spine Clinic, Sapporo 060-0042, Japan.
Takahito OoshimaDepartment of Radiological Technology, Tomakomai City Hospital, Tomakomai 053-8567, Japan.
Haruka TakahashiDepartment of X-ray Technology, Sapporo City General Hospital, Sapporo 060-8604, Japan.
National Institute of Technology, Tomakomai College · JPOtaru Municipal Hospital · JPSapporo City General Hospital · JPSapporo Medical University Hospital · JPSapporo Science Center · JPSapporo University · JP

Funding

Grant-in-Aid for Scientific Research provided by the Ministry of Education, Science, and Culture of Japan. 22791162
6 · The paper itself

Abstract

Non-small cell lung cancer (NSCLC) is an aggressive lung cancer accounting for approximately 85% of all lung cancer patients. For the patients with Stages IIIA, IIIB, and IIIC, the 5-year survival is low though with the combination with radiotherapy and chemotherapy. In addition, the occurrence of tumor cells (repopulated tumors) that survive irradiation remains a challenge. In our previous report, we subcloned the radiation-surviving tumor cells (IR cells) using the human NSCLC cell line, H1299, and found that the expression of neuropilin-1 (

Indexed as

Carcinoma, Non-Small-Cell LungCell Line, TumorCell MovementGene ExpressionHumansHuman Umbilical Vein Endothelial CellsIntegrin alphaVbeta3Lung NeoplasmsNeovascularization, PathologicNeuropilin-1Protein BindingRadiation ToleranceRNA, MessengerVascular Endothelial Growth Factor AIntegrin alphaVbeta3Neuropilin-1RNA, MessengerVascular Endothelial Growth Factor AVEGFA protein, humanmotilityneuropilinnon-small cell lung cancerradiotherapyrepopulated tumor

Identifiers

PMID34698100
PMCPMC8928997
OpenAlexW3200523597

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.